Skip to the page

Data / Form D filings / Boston Bioprocess, Inc.

Boston Bioprocess, Inc.: Form D filing

Boston Bioprocess, Inc., a technology company in Champaign, IL, filed a Form D with the SEC in 2024. The latest, on July 10, 2024, reports $6.3 million sold of a $6.5 million offering to 14 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
60 HAZELWOOD DRIVE, SUITE 218, Champaign, IL, 61820
Phone
(402) 617-9036
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2029645

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 10, 2024New notice$6,520,000$6,259,997$260,00314Jul 3, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Michael TaiExecutive Officer, Director
James CaffynDirector
Ted NetlandExecutive Officer, Director

Other technology companies in Illinois that filed recently

Every Form D from the week of Jul 8, 2024 · All recent filings in Illinois · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Boston Bioprocess, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.